- Home
- / Ultromics
Ultromics
Total Funding
$26 M
Revenue
£594.8 K
FY, 2021
Ultromics Summary
Company Summary
- Overview
- Ultromics is a health tech company that develops AI-powered echocardiography analysis solutions. Its products include EchoGo core, left ventricular (LV) analysis automation software; and EchoGo pro, coronary artery disease prediction software. The company serves health, cardiology practices, imaging centers, and pharma sectors.
- Type
- Private
- Status
- Active
- Founded
- 2017
- HQ
- Oxford, GB | view all locations
- Website
- https://www.ultromics.com
- Cybersecurity rating
Table of Contents
Key People
Paul Leeson, Founder and Chief Medical Officer
Helen Routh, Non-Executive Director
Amir Hasan, Chief Operating Officer
LocationsView all
3 locations detected
Oxford, England HQ
United Kingdom
Cascade Way, Oxford Business Park
Dallas, TX
United States
539 W Commerce St #1679
Oxford, England
United Kingdom
King Charles House, Park End St
Ultromics Financials
Summary Financials
- Revenue (FY, 2021)
- £594.8K
- Gross profit (FY, 2021)
- (£69.2K)
- Net income (FY, 2021)
- (£9.7M)
- Cash (FY, 2021)
- £19.7M
- EBIT (FY, 2021)
- (£10.8M)